Michael Krel
Directeur/Membre du Conseil chez AFYREN
Profil
Michael Krel's current jobs include being the Chairman at EnginZyme AB, a Director at Microphyt SA, a Director at Comet Biorefining, Inc., a Director at Afyren SAS, a Director at EnobraQ SAS, a Director at Elicit Plant SAS, a Director at Werewool, Inc., a Director at Meiogenix SAS, and a Partner at Sofinnova Partners SAS.
His former jobs include being a Director at Bon Vivant SAS and an Executive Vice President-Business Development at Deinove SA. Dr. Krel's education includes a doctorate from Ecole Polytechnique in 2005, an undergraduate degree from Ecole Polytechnique in 1997, and a doctorate from Université Paris Nanterre.
Postes actifs de Michael Krel
| Sociétés | Poste | Début |
|---|---|---|
| AFYREN | Directeur/Membre du Conseil | 11/06/2021 |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Private Equity Investor | 01/01/2020 |
EnobraQ SAS
 EnobraQ SAS Chemicals: Major DiversifiedProcess Industries EnobraQ SAS develops yeast for the production of chemical compounds. The company was founded on November 13, 2015 and is headquartered in Ramonville-Saint-Agne, France. | Directeur/Membre du Conseil | 01/02/2017 |
EnginZyme AB
 EnginZyme AB BiotechnologyHealth Technology EnginZyme AB is a Swedish company founded in 2014 by Samuel Härgestam, Robin Chatterjee, and Karim Engelmark Cassimjee. EnginZyme is based in Stockholm, Sweden, and has a multidisciplinary team of experts in biocatalysis, organic chemistry, enzyme and process engineering, as well as AI and machine learning. The company has developed a patented, cell-free biomanufacturing platform that combines the power of biology with the efficiencies of the chemical industry. EnginZyme aims to produce better, greener, and more affordable products sustainably. The company's enzyme immobilisation technology enables biomanufacturing without living organisms, resulting in lower costs and a smaller environmental footprint. The company has been recognized as a technology pioneer by the World Economic Forum and was selected for the Cleantech 100 list in 2022 and 2023. Karim Engelmark Cassimjee has been the CEO since 2014. | Président | 01/03/2020 |
Comet Biorefining, Inc.
 Comet Biorefining, Inc. BiotechnologyHealth Technology Comet Biorefining, Inc. operates as a holding company, which engages in the provision of cellulosic glucose technology for applications in renewable biofuels and biochemicals. It proprietary technology allows for the conversion of wood, wheat straw, bagasse, corn stover and other agricultural waste materials into high purity cellulosic glucose syrup. These non-food sources offer lower cost and price stability when compared to food sugar sources such as corn or sugar cane. The company was founded by Andrew Richard in 2009 and is headquartered in London, Canada. | Directeur/Membre du Conseil | 01/03/2016 |
Werewool, Inc.
 Werewool, Inc. TextilesProcess Industries Werewool, Inc. develops fibers. The CEO of the American company is Chui-Lian Lee. | Directeur/Membre du Conseil | 01/04/2023 |
Elicit Plant SAS
 Elicit Plant SAS Miscellaneous Commercial ServicesCommercial Services Elicit Plant SAS is a French agri-biotech company that aims to become a leader in the ecological transition for agriculture and address the challenges posed by climate change on large-scale crops. The company is based in Moulins-sur-Tardoire, France. The company's proprietary technology, based on the exogenous application of phytosterols, enhances plant stress resistance by eliciting their natural defenses. Extensive field trials across three continents have proven that the biosolutions from the eliterra® platform are the only ones providing farmers with a regular and sufficient return on investment for use in large-scale crops, yielding an average increase in productivity of 12%%. The company was founded in 2017 by Jean-François Dechant, who has been the CEO since 2017. | Directeur/Membre du Conseil | 01/09/2021 |
Microphyt SA
 Microphyt SA BiotechnologyHealth Technology Microphyt SA researches, develops, produces and markets natural bioactive products from microalgae. Its solutions are intended to address the needs of personal-care, food and health-care industries worldwide, through a differentiated and sustainable approach and proprietary technologies allow controlled and industrial-scale supply of microalgae biomass and extracts. The firm''s Industrial scale photo bioreactors developed and patented and are designed to produce specific strains of microalgae by preserving cell integrity and yielding commercial quantities of slow-growing or biofilm-forming species. The company was founded by Arnaud Muller-Feuga in 2007 and is headquartered in Baillargues, France. | Directeur/Membre du Conseil | - |
Meiogenix SAS
 Meiogenix SAS BiotechnologyHealth Technology Meiogenix SAS operates as a biotech company which develops breeding technologies. Its technology allows the modulation of the homologous recombination in eukaryotic cells. It facilitates the natural process that introduces genetic diversity in organisms allowing the generation of novel natural varieties. The company was founded by Giacomo Bastianelli and Alain Nicolas in 2011 and is headquartered in Paris, France. | Directeur/Membre du Conseil | 01/06/2021 |
Anciens postes connus de Michael Krel
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Michael Krel
| Ecole Polytechnique | Doctorate Degree |
| Université Paris Nanterre | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AFYREN | Health Technology |
| Entreprise privées | 10 |
|---|---|
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Finance |
Deinove SA
 Deinove SA BiotechnologyHealth Technology Deinove SA is a biotechnology company, which engages in the development of new-generation anti-infective antibiotics and bioactives. Its portfolio include Phy-N-Resist and HEBELYS. The company was founded by Philippe Pouletty and Miroslav Radman on October 11, 2006 and is headquartered in Grabels, France. | Health Technology |
Meiogenix SAS
Meiogenix SAS BiotechnologyHealth Technology Meiogenix SAS operates as a biotech company which develops breeding technologies. Its technology allows the modulation of the homologous recombination in eukaryotic cells. It facilitates the natural process that introduces genetic diversity in organisms allowing the generation of novel natural varieties. The company was founded by Giacomo Bastianelli and Alain Nicolas in 2011 and is headquartered in Paris, France. | Health Technology |
Microphyt SA
Microphyt SA BiotechnologyHealth Technology Microphyt SA researches, develops, produces and markets natural bioactive products from microalgae. Its solutions are intended to address the needs of personal-care, food and health-care industries worldwide, through a differentiated and sustainable approach and proprietary technologies allow controlled and industrial-scale supply of microalgae biomass and extracts. The firm''s Industrial scale photo bioreactors developed and patented and are designed to produce specific strains of microalgae by preserving cell integrity and yielding commercial quantities of slow-growing or biofilm-forming species. The company was founded by Arnaud Muller-Feuga in 2007 and is headquartered in Baillargues, France. | Health Technology |
EnobraQ SAS
EnobraQ SAS Chemicals: Major DiversifiedProcess Industries EnobraQ SAS develops yeast for the production of chemical compounds. The company was founded on November 13, 2015 and is headquartered in Ramonville-Saint-Agne, France. | Process Industries |
Elicit Plant SAS
Elicit Plant SAS Miscellaneous Commercial ServicesCommercial Services Elicit Plant SAS is a French agri-biotech company that aims to become a leader in the ecological transition for agriculture and address the challenges posed by climate change on large-scale crops. The company is based in Moulins-sur-Tardoire, France. The company's proprietary technology, based on the exogenous application of phytosterols, enhances plant stress resistance by eliciting their natural defenses. Extensive field trials across three continents have proven that the biosolutions from the eliterra® platform are the only ones providing farmers with a regular and sufficient return on investment for use in large-scale crops, yielding an average increase in productivity of 12%%. The company was founded in 2017 by Jean-François Dechant, who has been the CEO since 2017. | Commercial Services |
EnginZyme AB
EnginZyme AB BiotechnologyHealth Technology EnginZyme AB is a Swedish company founded in 2014 by Samuel Härgestam, Robin Chatterjee, and Karim Engelmark Cassimjee. EnginZyme is based in Stockholm, Sweden, and has a multidisciplinary team of experts in biocatalysis, organic chemistry, enzyme and process engineering, as well as AI and machine learning. The company has developed a patented, cell-free biomanufacturing platform that combines the power of biology with the efficiencies of the chemical industry. EnginZyme aims to produce better, greener, and more affordable products sustainably. The company's enzyme immobilisation technology enables biomanufacturing without living organisms, resulting in lower costs and a smaller environmental footprint. The company has been recognized as a technology pioneer by the World Economic Forum and was selected for the Cleantech 100 list in 2022 and 2023. Karim Engelmark Cassimjee has been the CEO since 2014. | Health Technology |
Werewool, Inc.
Werewool, Inc. TextilesProcess Industries Werewool, Inc. develops fibers. The CEO of the American company is Chui-Lian Lee. | Process Industries |
Bon Vivant SAS
 Bon Vivant SAS Food: Meat/Fish/DairyConsumer Non-Durables Bon Vivant SAS produces dairy products. The company is based in Lyon, France. The French company was founded in 2021. The CEO is Helene Briand. | Consumer Non-Durables |
Comet Biorefining, Inc.
Comet Biorefining, Inc. BiotechnologyHealth Technology Comet Biorefining, Inc. operates as a holding company, which engages in the provision of cellulosic glucose technology for applications in renewable biofuels and biochemicals. It proprietary technology allows for the conversion of wood, wheat straw, bagasse, corn stover and other agricultural waste materials into high purity cellulosic glucose syrup. These non-food sources offer lower cost and price stability when compared to food sugar sources such as corn or sugar cane. The company was founded by Andrew Richard in 2009 and is headquartered in London, Canada. | Health Technology |
